Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback